New Advances in COVID-19 and Pregnancy
Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. Therefore, there is a need to investigate the effects of...
Salvato in:
| Natura: | Online |
|---|---|
| Lingua: | inglese |
| Pubblicazione: |
MDPI - Multidisciplinary Digital Publishing Institute
2026
|
| Soggetti: | |
| Accesso online: | ONIX_20260416T142754_9783725859115_22 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1869515686077792256 |
|---|---|
| collection | Directory of Open Access Books |
| description | Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. Therefore, there is a need to investigate the effects of coronavirus disease 2019 (COVID-19) on the mortality of pregnant and postpartum women. Worldwide, there are more than 140 million births every year, and pregnant women are potentially at risk for adverse outcomes of novel coronavirus. Although maternal mortality has been reported in some studies, limited information is available about SARS-CoV-2 infection in critically ill pregnant women who are hospitalized for COVID-19. This Special Issue summarizes well-established data on the clinical manifestation of COVID-19 in pregnant women, maternal and perinatal outcomes associated with COVID-19, the risk of vertical transmission of the virus, and the effect of SARS-COV-2 infection during pregnancy on fetal and neonatal outcomes. The data provided by the papers included in this Special Issue will allow researchers to determine the maternal, fetal, and neonatal risk associated with SARS-COV-2 infection during pregnancy and may help to provide evidenced-based and personalized recommendations for the care of pregnant women with COVID-19. |
| format | Online |
| id | doab-20.500.12854ir-175067 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1750672026-04-16T18:45:50Z New Advances in COVID-19 and Pregnancy Cucinella, Gaspare COVID-19 SARS-CoV-2 Coronavirus infections Pregnancy COVID-19 and pregnancy Management Prevention Maternal outcomes Neonatal outcomes Infection Hospital admissions Emergency care Obstetric urgency Lockdown Restrictions Vaccination Preterm birth Stillbirth COVID -19 Alpha Delta Omicron Wild-type Infertility Personality traits Depression Assisted reproductive technology (ART) Fetomaternal Outcome Trimester Placenta Immunohistochemistry Diagnosis Pfizer vaccine CD44 Osteopontin COX2 Vitamin D receptor Intensive care unit admission Machine learning Feature importance Miscarriage Stress COVID-19 pandemic Viral infection COVID 19 Placental pathological lesions Neonatal oxidative stress SARS-CoV-2 fetal transmission Cesarean delivery Risk factors Neurodevelopment Infants Maternal infection Developmental delay Prenatal exposure SARS-CoV-2 infection Maternal morbidity Pregnancy complication Maternal comorbidities Severe disease Treatment thema EDItEUR::M Medicine and Nursing Based on what is known at this time, pregnant women are at an increased risk of severe illness from COVID-19 compared to nonpregnant women. Additionally, pregnant women with COVID-19 might have an increased risk of adverse pregnancy outcomes. Therefore, there is a need to investigate the effects of coronavirus disease 2019 (COVID-19) on the mortality of pregnant and postpartum women. Worldwide, there are more than 140 million births every year, and pregnant women are potentially at risk for adverse outcomes of novel coronavirus. Although maternal mortality has been reported in some studies, limited information is available about SARS-CoV-2 infection in critically ill pregnant women who are hospitalized for COVID-19. This Special Issue summarizes well-established data on the clinical manifestation of COVID-19 in pregnant women, maternal and perinatal outcomes associated with COVID-19, the risk of vertical transmission of the virus, and the effect of SARS-COV-2 infection during pregnancy on fetal and neonatal outcomes. The data provided by the papers included in this Special Issue will allow researchers to determine the maternal, fetal, and neonatal risk associated with SARS-COV-2 infection during pregnancy and may help to provide evidenced-based and personalized recommendations for the care of pregnant women with COVID-19. 2026-04-16T18:45:43Z 2026-04-16T18:45:43Z 2025 book ONIX_20260416T142754_9783725859115_22 9783725859115 9783725859122 https://directory.doabooks.org/handle/20.500.12854/175067 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/ https://mdpi.com/books/pdfview/book/11970 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-5912-2 10.3390/books978-3-7258-5912-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725859115 9783725859122 224 CH open access |
| spellingShingle | COVID-19 SARS-CoV-2 Coronavirus infections Pregnancy COVID-19 and pregnancy Management Prevention Maternal outcomes Neonatal outcomes Infection Hospital admissions Emergency care Obstetric urgency Lockdown Restrictions Vaccination Preterm birth Stillbirth COVID -19 Alpha Delta Omicron Wild-type Infertility Personality traits Depression Assisted reproductive technology (ART) Fetomaternal Outcome Trimester Placenta Immunohistochemistry Diagnosis Pfizer vaccine CD44 Osteopontin COX2 Vitamin D receptor Intensive care unit admission Machine learning Feature importance Miscarriage Stress COVID-19 pandemic Viral infection COVID 19 Placental pathological lesions Neonatal oxidative stress SARS-CoV-2 fetal transmission Cesarean delivery Risk factors Neurodevelopment Infants Maternal infection Developmental delay Prenatal exposure SARS-CoV-2 infection Maternal morbidity Pregnancy complication Maternal comorbidities Severe disease Treatment thema EDItEUR::M Medicine and Nursing New Advances in COVID-19 and Pregnancy |
| title | New Advances in COVID-19 and Pregnancy |
| title_full | New Advances in COVID-19 and Pregnancy |
| title_fullStr | New Advances in COVID-19 and Pregnancy |
| title_full_unstemmed | New Advances in COVID-19 and Pregnancy |
| title_short | New Advances in COVID-19 and Pregnancy |
| title_sort | new advances in covid 19 and pregnancy |
| topic | COVID-19 SARS-CoV-2 Coronavirus infections Pregnancy COVID-19 and pregnancy Management Prevention Maternal outcomes Neonatal outcomes Infection Hospital admissions Emergency care Obstetric urgency Lockdown Restrictions Vaccination Preterm birth Stillbirth COVID -19 Alpha Delta Omicron Wild-type Infertility Personality traits Depression Assisted reproductive technology (ART) Fetomaternal Outcome Trimester Placenta Immunohistochemistry Diagnosis Pfizer vaccine CD44 Osteopontin COX2 Vitamin D receptor Intensive care unit admission Machine learning Feature importance Miscarriage Stress COVID-19 pandemic Viral infection COVID 19 Placental pathological lesions Neonatal oxidative stress SARS-CoV-2 fetal transmission Cesarean delivery Risk factors Neurodevelopment Infants Maternal infection Developmental delay Prenatal exposure SARS-CoV-2 infection Maternal morbidity Pregnancy complication Maternal comorbidities Severe disease Treatment thema EDItEUR::M Medicine and Nursing |
| topic_facet | COVID-19 SARS-CoV-2 Coronavirus infections Pregnancy COVID-19 and pregnancy Management Prevention Maternal outcomes Neonatal outcomes Infection Hospital admissions Emergency care Obstetric urgency Lockdown Restrictions Vaccination Preterm birth Stillbirth COVID -19 Alpha Delta Omicron Wild-type Infertility Personality traits Depression Assisted reproductive technology (ART) Fetomaternal Outcome Trimester Placenta Immunohistochemistry Diagnosis Pfizer vaccine CD44 Osteopontin COX2 Vitamin D receptor Intensive care unit admission Machine learning Feature importance Miscarriage Stress COVID-19 pandemic Viral infection COVID 19 Placental pathological lesions Neonatal oxidative stress SARS-CoV-2 fetal transmission Cesarean delivery Risk factors Neurodevelopment Infants Maternal infection Developmental delay Prenatal exposure SARS-CoV-2 infection Maternal morbidity Pregnancy complication Maternal comorbidities Severe disease Treatment thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20260416T142754_9783725859115_22 |